Metrics
- Price
- $15.94
- Market Cap $M
- 84
- Rel Volume
- 0.05
- Vol Up 2W
- 44.4%
- Vol Trend 2W
- -36.4%
- 1D
- +0.2%
- 1W
- -1.6%
- 1M
- +13.6%
- 1M Slope
- +17.2%
- 6M Range
- 289.6%
- Score
- 79.8
- Sharp
- 4.1
Volume
Profile
Rallybio is a clinical-stage biotechnology company developing therapies for rare diseases, with programs focused on complement-mediated and hematologic disorders.
Biotech
Pharmaceuticals